IceCure Medical (ICCM) announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent titled “Cryoprobe”. This invention introduces a novel method for safely and efficiently extracting the cryoprobe after tissue freezing during cryoablation procedures. The cryoprobe’s tip is integrated with a heater, temperature sensor, and controlled gas pulses, enabling precise estimation and management of the cryoprobe’s external surface temperature-even while embedded in frozen tissue. Designed to be compatible with a wide range of XSense system cryoprobe types, the new cryoprobe technology is a versatile solution for multiple clinical scenarios.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCM:
- IceCure Medical Gains Israeli Approval for XSense™ Cryoablation System
- IceCure Medical receives approval in Israel for the XSense System
- IceCure Medical announces two publications for ProSense cryoablation system
- IceCure Medical files $100M mixed securities shelf
- IceCure Medical Shareholders Approve Key Agenda Items at Special Meeting